Keyword: CureVac


CureVac and MD Anderson Partner to Develop Cancer Vaccines

22.04.2024 -

Biopharmaceutical company CureVac has announced a co-development and licensing agreement with The University of Texas MD Anderson Cancer Center to develop novel mRNA...

Chemistry & Life Sciences

The Future of mRNA Technology

20.03.2024 -

mRNA-based vaccines against the coronavirus have become firmly established in medicine since the pandemic. Nevertheless, the technology is still at the beginning of its...


CureVac Presents Positive Data from mRNA Trials

01.02.2023 -

German biotech CureVac has released preliminary data from its ongoing cooperation with UK drugmaker GSK on a new class of “transformative medicines” based on messenger...


CureVac and GSK launch Phase 1 for Covid Booster

23.08.2022 -

CureVac and GSK have announced they are launching a Phase 1 clinical trial with their modified mRNA-based Covid 19 vaccine CV051, which would be recommended as a booster...


Pfizer and BioNTech Counter CureVac Lawsuit

03.08.2022 -

Pfizer and BioNTech are fighting back against CureVac’s lawsuit that asserts the makers of the Comirnaty-branded mRNA vaccine for Covid-19 infringed its patent.


CureVac Sues BioNTech for IP Infringement

07.07.2022 -

Germany’s BioNTech is pushing back against allegations by compatriot CureVac that the company infringed its intellectual property in formulating its mRNA-based Covid-19...


FDA Panel Recommends Approval of Nuaxovid

09.06.2022 -

In a vote of 21 in favor with one abstention, the US Food and Drug Administration’s advisory panel has recommended that the FDA approve Novavax’s Covid-19 vaccine...


Six Firms to Make Vaccines for German Emergency Supply

12.04.2022 -

Germany’s economics ministry has budgeted up to €2.9 billion ($3.14 billion) to ensure sufficient supply of mostly mRNA-based Covid-19 vaccines to be able to deal with...